The NUS Centre for Cancer Research recently held its Functional Precision Medicine Asia Symposium on 14 November 2023, where researchers from institutions locally and across Asia gathered to showcase the growing field of functional precision medicine in Asia. Dr Shruti was part of the organizing committee for this symposium. She gave the opening address, and her mentor, Dr Anthony Letai, was invited to give the keynote address.

​

During the symposium, Dr Shruti's talk on "Individual Drug Action Identifies Clinically Relevant Combinations for Acute Myeloid Leukemia" received much positive feedback. She went on to chair a panel session later on during the symposium.

​

One of our members, Shaista, also presented her lightning talk on "Mitochondrial Functional Profiling Links Apoptotic Sensitivity to Treatment Outcomes Based on Age and Cell Lineage in Acute Leukemia". She would go on to win the award for Best Oral Presentation, adding to further to the lab's achievements and efforts in cancer research this year.

​

Thank you for your effort Dr Shruti, and Congratulations, Shaista!

Frontiers in Cancer Science had recently held their 15th International Conference at the University Cultural Centre (UCC) from 6-8 November 2023. The Lab took the chance to attend the conference to gain valuable insight into cancer research from loval and international speakers.

​

Two of our members, Aarthi and Ahmed, had their posters accepted for the poster presentation. Aarthi's poster, titled "DFNA5 (GSDME) mediated pyroptosis is a driver for venetoclax and azacytidine synergy against myeloid leukemia" went on to win 3rd Prize in the Poster Presentation!

Congratulations Aarthi, for your achievement, and Well Done, both of you, for your work!

Our warmest congratulations to Dr Prasad Iyer for receiving the Teo Sok Yong and Goh Cheng Liang Childhood Cancer Grant by the KKH Children's Blood and Cancer Centre! With this grant, it is with hope that his work on Validating ex-vivo Bh3 profiling as a biomarker in identifying children with non-favourable risk Acute Myeloid Leukaemia may continue to change the many lives for families with children in our world today!
 

The 10th International MDM2 Workshop was held from October 15-18, 2023 in Tokyo, Japan.

Ahmed and Dr Shruti attended the workshop, and Ahmed's poster on "High-Throughput Drug Screening Identifies Novel Agents to Overcome Resistance to Venetoclax and Azacytidine in TP53 Mutated Leukemia" had impressed the evaluation committee and placed high hopes in our battle with leukemia resistance.

Congratulations to Lim En Tong for being awarded the Outstanding Undergraduate Researcher Prize (OURP) from the National University of Singapore!

Thank you to En Tong, Ke Xuan and Hoshea for contributing your hard work and efforts into our research, and good luck for all future endeavours! 

Our new Research Assistants, Nishta and Hoshea, have joined the lab!

We were awarded the MOE Tier 2 Grant. Thank you to MOE for funding our work on identifying mechanisms of therapeutic resistance in TP53 mutant leukemia patients!

Listen to her podcast here!

Shruti joins a network of EMBO Global Investigators 2023. Congratulations to Shruti!